Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |